Tailor-made or off-the-rack? The problem of transferability of health economic data

Editorial

Richard J Willke. Expert Rev Pharmacoecon Outcomes Res. 2003 Feb.

. 2003 Feb;3(1):1-4.

doi: 10.1586/14737167.3.1.1.

No abstract available

Similar articles

Transferability indices for health economic evaluations: methods and applications.
Antonanzas F, Rodríguez-Ibeas R, Juárez C, Hutter F, Lorente R, Pinillos M. Antonanzas F, et al. Health Econ. 2009 Jun;18(6):629-43. doi: 10.1002/hec.1397. Health Econ. 2009. PMID: 18677724
Guidelines for completing the EURONHEED transferability information checklists.
Nixon J, Rice S, Drummond M, Boulenger S, Ulmann P, de Pouvourville G. Nixon J, et al. Eur J Health Econ. 2009 May;10(2):157-65. doi: 10.1007/s10198-008-0115-4. Epub 2008 Jul 11. Eur J Health Econ. 2009. PMID: 18618158
Challenges in economic evaluation of new drugs: experience with rituximab in Hungary.
Brodszky V, Orlewska E, Pentek M, Karpati K, Skoupa J, Gulacsi L. Brodszky V, et al. Med Sci Monit. 2010 Jan;16(1):SR1-5. Med Sci Monit. 2010. PMID: 20037504
Transferability of economic evaluations of medical technologies: a new technology for orthopedic surgery.
Steuten L, Vallejo-Torres L, Young T, Buxton M. Steuten L, et al. Expert Rev Med Devices. 2008 May;5(3):329-36. doi: 10.1586/17434440.5.3.329. Expert Rev Med Devices. 2008. PMID: 18452383 Review.
[Managed care in Germany: legal and economic aspects of its transferability].
König HH, Seitz R. König HH, et al. Gesundheitswesen. 1999 Jun;61(6):274-9. Gesundheitswesen. 1999. PMID: 10429330 Review. German.